2.1 = | 1.762 Cit. to date |
842 Docs. to date |
Updated monthly
Editorial Office EJCRIM
2024-06-28
Views: 2396
SEARCH INDEX: 681
AS01.: 134
AS02.: 237
AS03.: 81
AS04.: 98
AS05.: 38
AS06.: 47
AS07.: 111
AS08.: 86
AS09.: 57
AS10.: 31
AS11.: 128
AS12.: 69
AS13.: 131
AS14.: 34
AS15.: 29
AS16.: 34
AS17.: 49
AS18.: 89
AS19.: 44
AS20.: 109
AS21.: 83
CONTENTS: 138
|
AS01. AMBULATORY MEDICINE
AS02. CARDIOVASCULAR DISEASES
AS03. CEREBROVASCULAR AND NEUROLOGIC DISEASES
AS04. COVID-19
AS05. DIGITAL HEALTH, TELEMEDICINE, INNOVATIVE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE
AS06. EMERGENCY AND ACUTE CARE MEDICINE
AS07. ENDOCRINE AND METABOLIC DISEASES
AS08. GASTROINTESTINAL AND LIVER DISEASES
AS09. GERIATRICS AND MULTIMORBIDITY
AS10. HEALTH MANAGEMENT
AS11. INFECTIOUS DISEASES
AS12. KIDNEY AND URINARY TRACT DISEASES
AS13. ONCOLOGIC AND HEMATOLOGIC DISEASES
AS14. ORGANIZATION AND QUALITY OF HEALTH CARE
AS15. PALLIATIVE CARE
AS16. PERIOPERATIVE MEDICINE
AS17. PREVENTIVE MEDICINE
AS18. RARE DISEASES
AS19. RESPIRATORY DISEASES
AS20. RHEUMATOLOGIC AND IMMUNE-MEDIATED DISEASES
AS21. OTHER
Due to the large number of abstracts received, a strategic approach is needed to find what you are looking for!
Use the Abstract Book SEARCH INDEX and follow the 3 simple steps.
Enjoy the read!
Rachelle Hamadi, Imad Karam, Salman Khan, Sylvester Homsy, Carol Luhrs
2024-07-01
Views: 44
HTML: 15
PDF: 35
|
Tumour-to-tumour metastasis (TTM) is a rare phenomenon that clinicians should be aware of when evaluating patients with a history of prostate cancer. We present the diagnosis and management of an 80-year-old former smoker with high-risk prostate cancer, who developed a lung nodule consistent with TTM. The patient had concurrent primary lung adenocarcinoma and metastatic prostate cancer, making this a unique case of dual primary and metastatic malignancies. The complexity of this case highlights the need for comprehensive evaluation and interdisciplinary management in patients with multiple malignancies. The literature review reveals that these are extremely rare occurrences, with most cases involving metastasis to the second primary tumour. Despite the challenges in diagnosing preoperatively, it is important to consider TTM as a possibility in patients with prostate cancer who present with a lung nodule. This report presents one of the few documented cases of TTM. It also reviews relevant cases in the literature and discusses the current situation in relation to established criteria for classifying combination tumours.
Joana Ferra, Cátia Guimarães, Cristina Matos, Fernando Nogueira
2021-02-05
Views: 1014
HTML: 54
PDF: 403
|
Synchronous tumours are defined as two or more independent primary neoplasms of different origins diagnosed at the same time in 1 individual. Although rare, its incidence is increasing and the proper diagnosis and staging of each tumour is crucial in defining the patient prognosis and the best therapeutic choice. We present a case of a 56-year-old woman presenting with a lung adenocarcinoma and pulmonary metastases initially diagnosed as stage IV and who was started on a tyrosine kinase inhibitor (erlotinib). In the meantime, she was also diagnosed with papillary thyroid carcinoma and was submitted to complete thyroidectomy. After 6 cycles of erlotinib, thoracic CT showed a decrease in the dimensions of the primary pulmonary tumour, but an increase in the size and number of pulmonary metastases while blood tests showed elevated thyroglobulin. This therefore raised the possibility that the metastases could have originated from the thyroid carcinoma. Anatomo-pathological examination of the lung metastases confirmed this hypothesis. In conclusion, it is important to confirm the origin of metastases in synchronous tumours given this can lead to a re-staging of tumours and a different prognosis, along with other therapeutic options. A multidisciplinary team meeting is crucial to define management and therapeutic approaches for these patients.
Dhairya Gor, Rohan Mehta, David Greenberg, Evgeniya Angelova
2022-07-07
Views: 554
HTML: 80
PDF: 355
|
It is rare for IgM multiple myeloma (MM) and mantle cell lymphoma (MCL) to coexist. Furthermore, it is challenging to demonstrate if there are two distinct types of neoplasia or if plasma cell differentiation of MCL is present. We discuss the case of a patient concomitantly diagnosed with MCL and IgM MM, and the subsequent diagnostic and management difficulties, and the positive treatment outcome.
Balraj Singh, Pooja Gogia, Parminder Kaur, Nirmal Guragai, Michael Maroules
2020-12-21
Views: 1225
HTML: 95
PDF: 604
|
Calcium elevation, Renal dysfunction, Anaemia and Bone disease (CRAB criteria) are usually seen in multiple myeloma (MM). We report a unique case of lymphoma with all the features of CRAB criteria. We describe a 59-year-old patient who presented with confusion, severe back pain, fatigue and constipation and was found to have hypercalcaemia, kidney dysfunction, anaemia and multiple osteolytic lesions. Physical examination and imaging did not reveal any enlarged lymph nodes. Work-up for MM (serum protein electrophoresis, serum immunofixation, bone marrow biopsy) was negative. The patient was diagnosed with diffuse large B-cell lymphoma based on a pelvic mass biopsy. Hence, our case report suggests that CRAB criteria are not pathognomonic of MM and that in the appropriate clinical scenario, lymphoma is a possible diagnosis.
Maaike Ramael, Patrick Schoeters, Karl De Pooter, Frederik Van Sonhoven, Hilde Van Steelandt, Jacqueline Swaegers, Wim Develter, Marc Ramael
2020-08-29
Views: 832
HTML: 133
PDF: 376
|
We describe the case of a 66-year-old woman with littoral cell angioma (LCA) confirmed by histopathology and immunohistochemistry, to our knowledge the first case in Belgium. LCA is an extremely rare primary vascular tumour of the splenic red pulp, probably originating from littoral cells. If a splenic mass and nodules are incidentally identified on imaging and the patient has no associated signs or symptoms, LCA should be suspected. Histopathology and adjacent techniques are mandatory for definitive diagnosis. Splenectomy followed by adequate follow-up is necessary to exclude underlying pathology.
2.1 = | 1.762 Cit. to date |
842 Docs. to date |
Official Journal of the
European Federation of Internal Medicine
www.efim.org
Publisher: SMC media Srl
Via Giovenale, 7 - 20136 Milan - Italy
P.IVA 07626490960
info@ejcrim.com
www.ejcrim.com - ISSN: 2284-2594 - © EFIM 2014-2024, Published by SMC Media srl, Italy - Privacy policy